Collaborations and top research areas from the last five years
Click on the circles to explore collaborations. Use the dropdown menu to filter on specific institutions.
Strategic Pillars
Our work focuses on strategic pillars that will drive significant growth in jobs & investment over the next five to fifteen years. These pillars align with the Governor’s Economic Development Plan.
About
Welcome to New Jersey’s first research asset database! ResearchwithNJ.com helps businesses and entrepreneurs identify and collaborate with our top universities and experts. This free database will help you discover thousands of experts in science, technology, engineering and mathematics (STEM) as well as their professional backgrounds, publications, and achievements. It will also help you learn about the research departments and specializations of our eight participating institutions: Hackensack Meridian Health, Kean University, Montclair State University, New Jersey Institute of Technology, Princeton University, Rowan University, Rutgers University and Stevens Institute of Technology.
ResearchwithNJ.com is sponsored by the New Jersey Commission on Science, Innovation and Technology. We invite you to explore our state’s vast array of intellectual capital and become part of New Jersey’s growing innovation ecosystem.
Why Choose New Jersey
|
|
|
Latest Research output
-
Efficacy of quabodepistat alone and in combination with delamanid and bedaquiline against Mycobacterium tuberculosis in an NHP model evaluated by [18F] FDG PET/CT and bacterial burden
Via, L. E., Sarathy, J., Weiner, D. M., Greenstein, T., Zimmerman, M., Abdi, A., Fleegle, J. D., Gomez, F., Kaya, F., Piazza, M. K., Vatthauer, A., Sloan, B. Y., Repoli, K. M., Walker, A. M., Woodcock, M. J., Egbelowo, O., Gausi, K., Boshoff, H. I. M., Liu, Y. & Chadalavada, D. & 3 others, , Oct 7 2026, In: Antimicrobial Agents and Chemotherapy. 70, 10, p. e0028026Hackensack Meridian School of Medicine
Research output: Contribution to journal › Article › peer-review
Open Access -
Inhibition of ROR1 signaling with zilovertamab plus ibrutinib in chronic lymphocytic leukemia: safety, mechanistic insights, and an exploratory signal in del(17p) disease
Choi, M. Y., Ghia, E. M., Siddiqi, T., Barrientos, J. C., Tuscano, J., Koff, J. L., Yazji, S., Leslie, L. A., Isufi, I., Lamanna, N., Goldenberg, A., Chung, G., Subbiah, S., Robinson, J. M., O’Neill, S., Jamieson, C. H. M., Breitmeyer, J. B., Wierda, W. G. & Kipps, T. J., 2026, (Accepted/In press) In: Leukemia.Hackensack Meridian School of Medicine
Research output: Contribution to journal › Article › peer-review
Open Access -
Re-evaluation of Patient Diagnosed With Multiple Sclerosis and Retinovascular Disease
Wieder, M. S., Mbekeani, J. N., Faust, P. L., Monoky, D. J., Ford, A. L., Atkinson, J. P. & Slamovits, T. L., 2026, (Accepted/In press) In: Journal of Neuro-Ophthalmology. 1.Hackensack Meridian School of Medicine
Research output: Contribution to journal › Article › peer-review
-
Autoencoder-Based Detection of Cyber-Physical Sabotage in Additive Manufacturing: A Preliminary Study
Heck, L., Castillo-Villar, K. K., Ciocarlie, G. & Sturm, L., 2026, IISE Annual Conference and Expo 2026. Xiang, Y., Yu, D. & Thiesing, R. (eds.). Institute of Industrial and Systems Engineers, IISE, p. 929-934 6 p. (IISE Annual Conference and Expo 2026; vol. 2).Stevens Institute of Technology
Research output: Chapter in Book/Report/Conference proceeding › Conference contribution › peer-review
-
Letter to the editor: precision nutrition should embrace and work to understand variability
Kleinberg, S., Oct 2026, In: American Journal of Clinical Nutrition. 124, 4, 101461.Stevens Institute of Technology
Research output: Contribution to journal › Letter › peer-review